/Companies

Ascendo Biotechnology, Inc.

1 known investors

Find your way into Ascendo Biotechnology, Inc.

Sign up to see every warm intro you have to Ascendo Biotechnology, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ascendo Biotechnology, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ascendo Biotechnology is a clinical-stage biopharmaceutical company developing innate immune checkpoint therapies for cancer and autoimmune disease. Its lead candidate, ASD141, is in Phase I trials for solid tumors resistant to existing treatments.

Investors · 1

Frequently asked questions

What does Ascendo Biotechnology, Inc. do?
Ascendo Biotechnology is a clinical-stage biopharmaceutical company developing innate immune checkpoint therapies for cancer and autoimmune disease. Its lead candidate, ASD141, is in Phase I trials for solid tumors resistant to existing treatments.
Who are Ascendo Biotechnology, Inc.'s investors?
Ascendo Biotechnology, Inc.'s investors include Axil Capital.